Stock Analysis
- Hong Kong
- /
- Medical Equipment
- /
- SEHK:2172
MicroPort NeuroScientific First Half 2024 Earnings: EPS: CN¥0.25 (vs CN¥0.11 in 1H 2023)
MicroPort NeuroScientific (HKG:2172) First Half 2024 Results
Key Financial Results
- Revenue: CN¥408.2m (up 36% from 1H 2023).
- Net income: CN¥143.5m (up 124% from 1H 2023).
- Profit margin: 35% (up from 21% in 1H 2023). The increase in margin was driven by higher revenue.
- EPS: CN¥0.25 (up from CN¥0.11 in 1H 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
MicroPort NeuroScientific Earnings Insights
Looking ahead, revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Medical Equipment industry in Hong Kong.
Performance of the Hong Kong Medical Equipment industry.
The company's shares are up 5.9% from a week ago.
Balance Sheet Analysis
Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on MicroPort NeuroScientific's balance sheet health.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:2172
MicroPort NeuroScientific
Engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally.